Table 2 MS-related healthcare costs before and during fampridine treatment
Pre-index period (before fampridine treatment) | Observation period (during fampridine treatment) | P-value | |
|---|---|---|---|
N = 562 | N = 562 | ||
Inpatient, mean (SD) | €1,565.42 (€3,335.18) | €1,333.42 (€3,882.73) | 0.0005 |
Median | €0 | €0 | |
Minimum, maximum | €0, €30,568.04 | €0, €62,415.54 | |
Physical therapy, mean (SD) | €810.89 (€887.80) | €963.92 (€925.50) | <0.0001 |
Median | €613.28 | €825.40 | |
Minimum, maximum | €0, €8,015.80 | €0, €6,945.80 | |
Outpatient, mean (SD) | €518.09 (€341.78) | €565.47 (€338.85) | <0.0001 |
Median | €459.33 | €508.52 | |
Minimum, maximum | €0, €2,794.88 | €0, €2,851.23 | |
Pharmacotherapy | |||
DMTs, mean (SD) | €7,684.42 (€8,908.24) | €8,604.78 (€9,948.43) | <0.0001 |
Median | €0 | €0 | |
Minimum, maximum | €0, €29,157.08 | €0, €33,639.54 | |
Corticosteroids, mean (SD) | €108.24 (€194.47) | €88.88 (€181.15) | 0.0054 |
Median | €0 | €0 | |
Minimum, maximum | €0, €989.38 | €0, €1,041.33 | |
Fampridine, mean (SD) | €0 (€0) | €5,519.32 (€1,565.83) | <0.0001 |
Median | €0 | €5,908.53 | |
Minimum, maximum | €0, €0 | €225.11, €10,033.99 | |
Other MS-related prescriptions, mean (SD) | €267.10 (€525.92) | €306.90 (€642.63) | 0.1229 |
Median | €52.16 | €55.53 | |
Minimum, maximum | €0, €4,782.96 | €0, €7,358.06 | |
Devices for mobility problems, mean (SD) | €6.09 (€26.95) | €9.17 (€58.20) | 0.7468 |
Median | €0 | €0 | |
Minimum, maximum | €0, €344.01 | €0, €1,146.39 | |
Total MS-related healthcare, mean (SD) | €10,960.26 (€9,030.32) | €17,391.86 (€10,325.65) | <0.0001 |
Median | €9,376.59 | €14,447.76 | |
Minimum, maximum | €0, €44,126.80 | €1,107.41, €67,001.71 | |